Surgical Site Infection

Accurately measure, detect, and prevent surgical site infections through patient-reported data.

Surgical Site Infection (SSI) surveillance is a critical safety process to identify SSI risks and prevent serious harm.

With shorter hospital stays, surveillance increasingly needs to be done post-discharge, but traditional surveillance methods (readmission to hospital, pathology results) significantly underreport true incidence rates. Using a Public Health England-validated patient-reported survey, we accurately measure SSI incidence and alert infection prevention and control (IPC) teams when patients report concerning symptoms. This can be done at a fraction of the cost of other approaches.

Why Surgical Site Infection?

Accurately Measure SSI Incidence

Using a Public Health England-validated survey, we capture real-time patient-reported data, ensuring a more accurate measure of SSI incidence compared to traditional methods.

Detect Infections Early

By collecting post-discharge feedback, we enable early detection of infection symptoms, allowing Infection Prevention and Control (IPC) teams to respond quickly and prevent complications.

Reduce Underreporting of SSIs

Traditional surveillance methods often miss true infection rates. Our system ensures a more complete picture by collecting data directly from patients, improving the accuracy of SSI reporting.

Lower Surveillance Costs

Our patient-reported survey approach offers significant cost savings compared to traditional surveillance methods like readmissions and pathology tests, providing an affordable solution for SSI monitoring.

Enhance Patient Safety and Outcomes

By identifying and addressing SSIs early, our approach helps reduce the risk of serious harm, supporting better post-surgical outcomes and improving overall patient safety.

Whitepaper

Taking your Post-Discharge Surgical Site Infection Surveillance Digital

Capturing patient feedback across their healthcare journey.

Trusted by private hospitals worldwide

Want to know more about our solutions? Speak to our expert.

Paul Millett, Director of Global Business Development